Guess who crawls out of the woodwork


Right on cue, legal troll Rigrodsky & Long announces its investigation (and shareholder recruitment) into whether the Idenix (IDIX +231.8%) BOD breached its fiduciary duty by not shopping the company around before agreeing to Merck's (MRK -0.1%) $24.50/share offer. Apparently, a ~240% premium isn't enough.

Comments (3)
  • ChiefKing
    , contributor
    Comments (147) | Send Message
     
    Please...
    9 Jun 2014, 02:46 PM Reply Like
  • newnnly
    , contributor
    Comments (383) | Send Message
     
    Now that's funny
    9 Jun 2014, 05:52 PM Reply Like
  • MichaelJ8
    , contributor
    Comments (869) | Send Message
     
    actually a 240% increase is way undervalued... This is one of the few lawuists I agree with.

     

    IDIX should have been worth closer to 10billion.
    9 Jun 2014, 06:17 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs